Evaluation of Molecular Profiles in Calcineurin Inhibitor Toxicity Post-Kidney Transplant: Input to Chronic Allograft Dysfunction

Endothelial cell transforming growth factor-β receptor activation causes tacrolimus-induced renal arteriolar hyalinosis

(2012) Valorie L. Chiasson et al.   KIDNEY INTERNATIONAL

Challenges and considerations in diagnosing the kidney disease in deteriorating graft function

(2012) Henrik Ekberg et al.   TRANSPLANT INTERNATIONAL

Chronic renal allograft injury: early detection, accurate diagnosis and management

(2012) Julio Pascual et al.   Transplantation Reviews

Histological Characteristics of Calcineurin Inhibitor Toxicity-There Is No Such Thing as Specificity!

(2011) M. Mengel et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Specificity of Histological Markers of Long-Term CNI Nephrotoxicity in Kidney-Transplant Recipients Under Low-Dose Cyclosporine Therapy

(2011) R. Snanoudj et al.   AMERICAN JOURNAL OF TRANSPLANTATION

MicroRNA Profiles in Allograft Tissues and Paired Urines Associate With Chronic Allograft Dysfunction With IF/TA

(2011) M. J. Scian et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence

(2011) J. Sellarés et al.   AMERICAN JOURNAL OF TRANSPLANTATION

ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantation

(2011) Nauras Shuker et al.   CLINICA CHIMICA ACTA

Diagnosis and prevention of chronic kidney allograft loss

(2011) Brian J Nankivell et al.   LANCET

CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation

(2011) François Glowacki et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effect of a new functionalCYP3A4polymorphism on calcineurin inhibitors’ dose requirements and trough blood levels in stable renal transplant patients

(2011) Laure Elens et al.   PHARMACOGENOMICS

Challenges in diagnosing acute calcineurin-inhibitor induced nephrotoxicity: From toxicogenomics to emerging biomarkers

(2011) Nicolas Pallet et al.   PHARMACOLOGICAL RESEARCH

Genomic-Derived Markers for Early Detection of Calcineurin Inhibitor Immunosuppressant–Mediated Nephrotoxicity

(2011) Yuxia Cui et al.   TOXICOLOGICAL SCIENCES

Chronic Renal Allograft Damage: Existing Challenges

(2011) Manuel Arias et al.   TRANSPLANTATION

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II

(2010) Christine E. Staatz et al.   CLINICAL PHARMACOKINETICS

Whole blood flow cytometric measurement of NFATc1 and IL-2 expression to analyze cyclosporine A-mediated effects in T cells

(2010) Claudia Brandt et al.   CYTOMETRY PART A

Immune monitoring and biomarkers to predict chronic allograft dysfunction

(2010) Roslyn B. Mannon   KIDNEY INTERNATIONAL

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

(2009)   AMERICAN JOURNAL OF TRANSPLANTATION

The Alphabet Soup of Kidney Transplantation: SCD, DCD, ECD--Fundamentals for the Practicing Nephrologist

(2009) P. S. Rao et al.   Clinical Journal of the American Society of Nephrology

Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions

(2008) K. Solez et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Unknown

(2008) Daniel Maluf et al.   MOLECULAR MEDICINE

Susceptibility of Human Mesenchymal Stem Cells to Tacrolimus, Mycophenolic Acid, and Rapamycin

(2008) Martin J. Hoogduijn et al.   TRANSPLANTATION

Effects of Immunosuppressive Drugs On Purified Human B Cells: Evidence Supporting the Use of MMF and Rapamycin

(2008) Sebastiaan Heidt et al.   TRANSPLANTATION